Aspira Pathlab
add_icon

Aspira Pathlab

62.17
0.00
(0.00%)
Market Cap
64.00 Cr
PE Ratio
26.68
Volume
577.00
Day High - Low
65.40 - 62.17
52W High-Low
106.78 - 50.49
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
64.00 Cr
EPS
1.97
PE Ratio
26.68
PB Ratio
8.84
Book Value
7.03
EBITDA
3.90
Dividend Yield
0.00 %
Return on Equity
16.62
Debt to Equity
0.15
Forecast For
Actual

Company News

View All News
Caret
neutral
Aspira Pathlab & Diagnostics Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended December 31, 2025, confirming proper dematerialisation processes.
negative
Aspira Pathlab & Diagnostics Limited announces the demise of Independent Director Dr. Alaka Keshav Deshpande, aged 79, who passed away on December 30, 2025. She served on multiple board committees.
negative
Aspira Pathlab Diagnostics Limited reported a net loss of ₹230.49 lakhs for the second quarter ended September 30, 2025, compared to a profit of ₹97.36 lakhs in the same period last year. The company's board approved the appointment of Mrs. Kiran Raghavendra Awasthi as Additional Independent Director for a five-year term starting November 12, 2025, subject to member approval. Mrs. Awasthi is a Chartered Accountant with 28 years of experience in accounts, finance, and taxation, and serves as Senior Partner at AMRG Associates. The company acquired the business undertaking of Aspira DNA Diagnostics Gujarat LLP for ₹13.00 lakhs, effective from June 30, 2025. Following this acquisition, the LLP ceased operations and is winding up, resulting in the company having no subsidiaries, associates, or joint ventures as of September 30, 2025.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,381.00
#1 23,138.80
43.98
#1 2,554.80
11.28
#1 492
16.36
35.21
984.10
10,109.16
67.08
699.70
23.06
144
2.85
38.77
1,875.10
9,717.14
62.80
1,346.30
10.64
146
13.28
43.29
452.60
7,203.66
57.28
702.20
20.80
91
81.06
49.63
485.60
4,872.55
73.85
769.90
33.97
67
-
53.55
718.40
2,330.39
28.03
742.70
16.70
78
22.45
40.49
276.05
1,437.69
45.92
255.90
15.11
31
-13.73
48.18
1,496.20
1,284.13
25.37
111.60
28.72
48
0.67
61.80
540.00
1,055.36
#1 24.96
147.80
#1 134.60
19
#1 760.87
43.02
324.50
1,032.25
-112.84
1,170.80
-18.47
-134
90.05
66.20
Growth Rate
Revenue Growth
64.71 %
Net Income Growth
-174.07 %
Cash Flow Change
74.29 %
ROE
-163.10 %
ROCE
-186.18 %
EBITDA Margin (Avg.)
-411.03 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
3
4
5
6
6
6
5
Expenses
3
4
4
5
5
5
5
EBITDA
-0
-0
0
1
1
1
1
Operating Profit %
-17 %
-5 %
6 %
21 %
11 %
16 %
13 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
-1
-1
0
1
0
1
0
Tax
0
0
0
0
0
0
0
Net Profit
-1
-1
0
1
0
1
0
EPS in ₹
-0.70
-0.49
0.05
0.96
0.30
0.66
0.41

Balance Sheet

Balance Sheet
2024
2025
Total Assets
15
18
Fixed Assets
7
7
Current Assets
4
5
Capital Work in Progress
0
0
Investments
0
0
Other Assets
8
11
Total Liabilities
15
18
Current Liabilities
2
2
Non Current Liabilities
3
3
Total Equity
10
12
Reserve & Surplus
-5
-3
Share Capital
10
10

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
1
Investing Activities
0
0
Operating Activities
1
2
Financing Activities
-1
-1

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
36.25 %
36.25 %
36.25 %
36.25 %
36.25 %
36.25 %
36.19 %
34.55 %
19.48 %
19.47 %
19.37 %
19.37 %
18.90 %
18.90 %
18.72 %
18.72 %
18.55 %
18.55 %
18.39 %
18.39 %
18.39 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
40.41 %
40.41 %
40.41 %
40.33 %
40.33 %
41.47 %
43.33 %
40.92 %
52.60 %
51.49 %
51.76 %
51.76 %
52.24 %
51.99 %
55.71 %
59.15 %
61.26 %
60.28 %
60.46 %
60.28 %
60.16 %
Others
23.34 %
23.34 %
23.34 %
23.42 %
23.42 %
22.28 %
20.48 %
24.54 %
27.91 %
29.04 %
28.87 %
28.87 %
28.86 %
29.11 %
25.57 %
22.13 %
20.19 %
21.18 %
21.15 %
21.33 %
21.45 %
No of Share Holders
536
535
535
710
852
868
955
1,141
1,300
1,300
1,371
1,371
1,406
1,351
1,512
1,695
1,706
1,593
1,741
1,770
1,755

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Nov 2016 CHANGE OF NAME Change Of Name
NA
16 Nov 2016 0.00 0.00
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 32.42 41.39
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 50.14 61.75
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 77.00 70.07
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 63.93 56.05
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 69.30 65.00
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 63.00 61.87
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 60.97 60.77

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot6 days ago
Announcement under Regulation 30 (LODR)-Demise7 days ago
Announcement under Regulation 30 (LODR)-Demise10 days ago
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 12, 2025
Standalone Financial Results And Limited Review Report As On September 30 2025Nov 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On November 12 2025Nov 12, 2025
Board Meeting Intimation for The Board Meeting To Be Held On November 12 2025Nov 04, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesOct 13, 2025
Draft Letter of OfferOct 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Disclosure Regarding Detailed Public Statement ("DPS") In Relation To The Open Offer To The Public ShareholdersOct 06, 2025
Detailed Public StatementOct 06, 2025
Announcement under Regulation 30 (LODR)-CessationSep 27, 2025
Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferSep 26, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateSep 26, 2025
Appointment Of Secretarial Auditor Of The CompanySep 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 26, 2025
Public Announcement - Open OfferSep 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Letters Dispatched To Non-Email ShareholdersSep 04, 2025
Notice Convening 52Nd Annual General Meeting To Be Held On Friday September 26 2025 At 02.00 P.M Through Video Conferencing Mode.Sep 04, 2025
Reg. 34 (1) Annual Report.Sep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Book Closure Record Date & E-Voting Intimation For The Purpose Of 52Nd Annual General Meeting.Aug 29, 2025
52Nd Annual General Meeting To Be Held On Friday September 26 2025 At 02.00 P.M (IST) Through Video Conferencing / Other Audio Visual Means.Aug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 12, 2025
Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On August 12 2025Aug 12, 2025
Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended On June 30 2025 And To Transact Other Businesses.Aug 02, 2025
Re-Appointment Of Dr. Pankaj J. Shah (DIN:02836324) As Managing Director & CEO For A Period Of Three (3) Years. Jul 10, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Inauguration Of Three (3) New Diagnostics Centers In Gujarat.Jul 01, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 01, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 10, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 09, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 02, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015May 28, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
100% Acquisition Of Stake And Strike Off Of Aspira DNA Diagnostics Gujarat LLPMay 16, 2025
Re-Appointment Of Dr. Pankaj Shah (DIN: 02836324) As Managing Director & CEO Subject To The Members Approval For A Period Of Three (3) YearsMay 16, 2025

Technical Indicators

RSI(14)
Neutral
43.77
ATR(14)
Volatile
4.40
STOCH(9,6)
Neutral
45.08
STOCH RSI(14)
Oversold
17.28
MACD(12,26)
Bearish
-0.29
ADX(14)
Weak Trend
15.39
UO(9)
Bearish
39.08
ROC(12)
Downtrend And Accelerating
-0.61
WillR(14)
Neutral
-67.57